nodes	percent_of_prediction	percent_of_DWPC	metapath
Ponatinib—FGFR4—respiratory system—idiopathic pulmonary fibrosis	0.0674	0.107	CbGeAlD
Ponatinib—FGFR3—respiratory system—idiopathic pulmonary fibrosis	0.046	0.0733	CbGeAlD
Ponatinib—BCR—respiratory system—idiopathic pulmonary fibrosis	0.0398	0.0634	CbGeAlD
Ponatinib—FLT3—respiratory system—idiopathic pulmonary fibrosis	0.0395	0.063	CbGeAlD
Ponatinib—FGFR4—lung—idiopathic pulmonary fibrosis	0.0358	0.0571	CbGeAlD
Ponatinib—FGFR2—respiratory system—idiopathic pulmonary fibrosis	0.0301	0.048	CbGeAlD
Ponatinib—TEK—respiratory system—idiopathic pulmonary fibrosis	0.0289	0.046	CbGeAlD
Ponatinib—BCR—Rho GTPase cycle—FAM13A—idiopathic pulmonary fibrosis	0.0278	0.0745	CbGpPWpGaD
Ponatinib—RET—Posttranslational regulation of adherens junction stability and dissassembly—DSP—idiopathic pulmonary fibrosis	0.0266	0.0713	CbGpPWpGaD
Ponatinib—PDGFRA—respiratory system—idiopathic pulmonary fibrosis	0.0261	0.0417	CbGeAlD
Ponatinib—SRC—respiratory system—idiopathic pulmonary fibrosis	0.0256	0.0409	CbGeAlD
Ponatinib—FGFR3—lung—idiopathic pulmonary fibrosis	0.0244	0.0389	CbGeAlD
Ponatinib—KDR—respiratory system—idiopathic pulmonary fibrosis	0.0236	0.0376	CbGeAlD
Ponatinib—BCR—lung—idiopathic pulmonary fibrosis	0.0211	0.0337	CbGeAlD
Ponatinib—FLT3—lung—idiopathic pulmonary fibrosis	0.021	0.0334	CbGeAlD
Ponatinib—KIT—respiratory system—idiopathic pulmonary fibrosis	0.0209	0.0333	CbGeAlD
Ponatinib—FGFR1—lung—idiopathic pulmonary fibrosis	0.0188	0.03	CbGeAlD
Ponatinib—ABL1—respiratory system—idiopathic pulmonary fibrosis	0.0182	0.029	CbGeAlD
Ponatinib—LCK—lung—idiopathic pulmonary fibrosis	0.0168	0.0268	CbGeAlD
Ponatinib—FGFR2—lung—idiopathic pulmonary fibrosis	0.016	0.0255	CbGeAlD
Ponatinib—TEK—lung—idiopathic pulmonary fibrosis	0.0153	0.0244	CbGeAlD
Ponatinib—PDGFRA—lung—idiopathic pulmonary fibrosis	0.0139	0.0221	CbGeAlD
Ponatinib—SRC—lung—idiopathic pulmonary fibrosis	0.0136	0.0217	CbGeAlD
Ponatinib—KDR—lung—idiopathic pulmonary fibrosis	0.0125	0.02	CbGeAlD
Ponatinib—KIT—lung—idiopathic pulmonary fibrosis	0.0111	0.0177	CbGeAlD
Ponatinib—CYP3A5—respiratory system—idiopathic pulmonary fibrosis	0.0106	0.017	CbGeAlD
Ponatinib—ABL1—lung—idiopathic pulmonary fibrosis	0.00966	0.0154	CbGeAlD
Ponatinib—ABL1—Posttranslational regulation of adherens junction stability and dissassembly—DSP—idiopathic pulmonary fibrosis	0.00915	0.0245	CbGpPWpGaD
Ponatinib—ABL1—Regulation of retinoblastoma protein—SFTPD—idiopathic pulmonary fibrosis	0.00834	0.0224	CbGpPWpGaD
Ponatinib—FGFR4—Syndecan-2-mediated signaling events—FN1—idiopathic pulmonary fibrosis	0.00805	0.0216	CbGpPWpGaD
Ponatinib—SRC—Posttranslational regulation of adherens junction stability and dissassembly—DSP—idiopathic pulmonary fibrosis	0.00667	0.0179	CbGpPWpGaD
Ponatinib—TEK—Angiopoietin receptor Tie2-mediated signaling—FN1—idiopathic pulmonary fibrosis	0.00666	0.0179	CbGpPWpGaD
Ponatinib—FGFR4—FGF signaling pathway—PLAU—idiopathic pulmonary fibrosis	0.00626	0.0168	CbGpPWpGaD
Ponatinib—ABCG2—lung—idiopathic pulmonary fibrosis	0.00609	0.00971	CbGeAlD
Ponatinib—LYN—Signaling by Interleukins—TOLLIP—idiopathic pulmonary fibrosis	0.00608	0.0163	CbGpPWpGaD
Ponatinib—FGFR3—Syndecan-2-mediated signaling events—FN1—idiopathic pulmonary fibrosis	0.00596	0.016	CbGpPWpGaD
Ponatinib—RET—Dopaminergic Neurogenesis—TGFB1—idiopathic pulmonary fibrosis	0.00591	0.0158	CbGpPWpGaD
Ponatinib—ABCB1—respiratory system—idiopathic pulmonary fibrosis	0.00566	0.00902	CbGeAlD
Ponatinib—CYP3A5—lung—idiopathic pulmonary fibrosis	0.00565	0.00902	CbGeAlD
Ponatinib—TEK—Rac1/Pak1/p38/MMP-2 pathway—FN1—idiopathic pulmonary fibrosis	0.00527	0.0141	CbGpPWpGaD
Ponatinib—LCK—Signaling by Interleukins—TOLLIP—idiopathic pulmonary fibrosis	0.00498	0.0134	CbGpPWpGaD
Ponatinib—SRC—GRB2:SOS provides linkage to MAPK signaling for Integrins—FN1—idiopathic pulmonary fibrosis	0.00491	0.0132	CbGpPWpGaD
Ponatinib—SRC—p130Cas linkage to MAPK signaling for integrins—FN1—idiopathic pulmonary fibrosis	0.00491	0.0132	CbGpPWpGaD
Ponatinib—KDR—Beta3 integrin cell surface interactions—PLAU—idiopathic pulmonary fibrosis	0.00484	0.013	CbGpPWpGaD
Ponatinib—FGFR3—FGF signaling pathway—PLAU—idiopathic pulmonary fibrosis	0.00463	0.0124	CbGpPWpGaD
Ponatinib—KDR—Beta3 integrin cell surface interactions—FN1—idiopathic pulmonary fibrosis	0.0045	0.0121	CbGpPWpGaD
Ponatinib—FGFR4—Syndecan-2-mediated signaling events—TGFB1—idiopathic pulmonary fibrosis	0.00423	0.0113	CbGpPWpGaD
Ponatinib—FGFR1—Syndecan-4-mediated signaling events—FN1—idiopathic pulmonary fibrosis	0.0042	0.0113	CbGpPWpGaD
Ponatinib—FGFR4—Syndecan-1-mediated signaling events—TGFB1—idiopathic pulmonary fibrosis	0.00405	0.0109	CbGpPWpGaD
Ponatinib—FGFR3—Endochondral Ossification—PLAU—idiopathic pulmonary fibrosis	0.00404	0.0108	CbGpPWpGaD
Ponatinib—TEK—Cell surface interactions at the vascular wall—FN1—idiopathic pulmonary fibrosis	0.00386	0.0103	CbGpPWpGaD
Ponatinib—KDR—Integrins in angiogenesis—FN1—idiopathic pulmonary fibrosis	0.00332	0.0089	CbGpPWpGaD
Ponatinib—SRC—Alpha9 beta1 integrin signaling events—FN1—idiopathic pulmonary fibrosis	0.00326	0.00875	CbGpPWpGaD
Ponatinib—KDR—Integrin cell surface interactions—FN1—idiopathic pulmonary fibrosis	0.0032	0.00857	CbGpPWpGaD
Ponatinib—LCK—Inflammatory Response Pathway—FN1—idiopathic pulmonary fibrosis	0.00319	0.00855	CbGpPWpGaD
Ponatinib—FGFR2—FGF signaling pathway—PLAU—idiopathic pulmonary fibrosis	0.00319	0.00855	CbGpPWpGaD
Ponatinib—FGFR3—Syndecan-2-mediated signaling events—TGFB1—idiopathic pulmonary fibrosis	0.00313	0.00839	CbGpPWpGaD
Ponatinib—SRC—Integrin alphaIIb beta3 signaling—FN1—idiopathic pulmonary fibrosis	0.00307	0.00823	CbGpPWpGaD
Ponatinib—LCK—IL2 signaling events mediated by PI3K—TERT—idiopathic pulmonary fibrosis	0.00306	0.00821	CbGpPWpGaD
Ponatinib—ABCB1—lung—idiopathic pulmonary fibrosis	0.003	0.00479	CbGeAlD
Ponatinib—FGFR3—Syndecan-1-mediated signaling events—TGFB1—idiopathic pulmonary fibrosis	0.003	0.00804	CbGpPWpGaD
Ponatinib—SRC—Nanoparticle-mediated activation of receptor signaling—FN1—idiopathic pulmonary fibrosis	0.00298	0.00799	CbGpPWpGaD
Ponatinib—FGFR1—FGF signaling pathway—PLAU—idiopathic pulmonary fibrosis	0.00297	0.00796	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—FAM13A—idiopathic pulmonary fibrosis	0.00294	0.00788	CbGpPWpGaD
Ponatinib—LYN—Cytokine Signaling in Immune system—TOLLIP—idiopathic pulmonary fibrosis	0.00284	0.00761	CbGpPWpGaD
Ponatinib—FGFR1—Mesodermal Commitment Pathway—SMAD3—idiopathic pulmonary fibrosis	0.00278	0.00746	CbGpPWpGaD
Ponatinib—PDGFRA—ATF-2 transcription factor network—PLAU—idiopathic pulmonary fibrosis	0.00276	0.0074	CbGpPWpGaD
Ponatinib—SRC—Alpha4 beta1 integrin signaling events—FN1—idiopathic pulmonary fibrosis	0.00261	0.00701	CbGpPWpGaD
Ponatinib—FGFR1—Glypican 1 network—TGFB1—idiopathic pulmonary fibrosis	0.0026	0.00698	CbGpPWpGaD
Ponatinib—FGFR1—Endochondral Ossification—PLAU—idiopathic pulmonary fibrosis	0.00259	0.00695	CbGpPWpGaD
Ponatinib—FGFR4—Regulation of Actin Cytoskeleton—FN1—idiopathic pulmonary fibrosis	0.00258	0.00693	CbGpPWpGaD
Ponatinib—ABL1—Regulation of Telomerase—SMAD3—idiopathic pulmonary fibrosis	0.00249	0.00669	CbGpPWpGaD
Ponatinib—SRC—Syndecan-2-mediated signaling events—FN1—idiopathic pulmonary fibrosis	0.00244	0.00654	CbGpPWpGaD
Ponatinib—SRC—Platelet Aggregation (Plug Formation)—FN1—idiopathic pulmonary fibrosis	0.00238	0.0064	CbGpPWpGaD
Ponatinib—LCK—Cytokine Signaling in Immune system—TOLLIP—idiopathic pulmonary fibrosis	0.00232	0.00623	CbGpPWpGaD
Ponatinib—SRC—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—PLAU—idiopathic pulmonary fibrosis	0.00232	0.00622	CbGpPWpGaD
Ponatinib—LYN—Glypican 1 network—TGFB1—idiopathic pulmonary fibrosis	0.00229	0.00614	CbGpPWpGaD
Ponatinib—ABL1—Regulation of Telomerase—TERT—idiopathic pulmonary fibrosis	0.00228	0.00612	CbGpPWpGaD
Ponatinib—FGFR4—Immune System—TOLLIP—idiopathic pulmonary fibrosis	0.00222	0.00595	CbGpPWpGaD
Ponatinib—SRC—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—FN1—idiopathic pulmonary fibrosis	0.00215	0.00578	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—FAM13A—idiopathic pulmonary fibrosis	0.00207	0.00555	CbGpPWpGaD
Ponatinib—ABCG2—HIF-1-alpha transcription factor network—SMAD3—idiopathic pulmonary fibrosis	0.00204	0.00547	CbGpPWpGaD
Ponatinib—KDR—Cardiac Progenitor Differentiation—TGFB1—idiopathic pulmonary fibrosis	0.002	0.00537	CbGpPWpGaD
Ponatinib—FGFR3—Endochondral Ossification—TGFB1—idiopathic pulmonary fibrosis	0.00197	0.0053	CbGpPWpGaD
Ponatinib—ABCG2—Transmembrane transport of small molecules—ATP11A—idiopathic pulmonary fibrosis	0.00197	0.00527	CbGpPWpGaD
Ponatinib—FGFR3—Regulation of Actin Cytoskeleton—FN1—idiopathic pulmonary fibrosis	0.00191	0.00513	CbGpPWpGaD
Ponatinib—SRC—FGF signaling pathway—PLAU—idiopathic pulmonary fibrosis	0.0019	0.00508	CbGpPWpGaD
Ponatinib—LCK—Glypican 1 network—TGFB1—idiopathic pulmonary fibrosis	0.00188	0.00503	CbGpPWpGaD
Ponatinib—ABCG2—HIF-1-alpha transcription factor network—TERT—idiopathic pulmonary fibrosis	0.00187	0.005	CbGpPWpGaD
Ponatinib—SRC—AGE/RAGE pathway—SMAD3—idiopathic pulmonary fibrosis	0.00186	0.00499	CbGpPWpGaD
Ponatinib—ABL1—Cell Cycle—SMAD3—idiopathic pulmonary fibrosis	0.0018	0.00484	CbGpPWpGaD
Ponatinib—ABL1—DNA Damage Response (only ATM dependent)—SMAD3—idiopathic pulmonary fibrosis	0.00171	0.00459	CbGpPWpGaD
Ponatinib—KIT—Differentiation Pathway—TGFB1—idiopathic pulmonary fibrosis	0.00168	0.0045	CbGpPWpGaD
Ponatinib—SRC—Glypican 1 network—TGFB1—idiopathic pulmonary fibrosis	0.00166	0.00446	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—TOLLIP—idiopathic pulmonary fibrosis	0.00164	0.0044	CbGpPWpGaD
Ponatinib—SRC—Integrins in angiogenesis—FN1—idiopathic pulmonary fibrosis	0.00156	0.00418	CbGpPWpGaD
Ponatinib—KIT—Cardiac Progenitor Differentiation—TGFB1—idiopathic pulmonary fibrosis	0.00155	0.00416	CbGpPWpGaD
Ponatinib—FGFR2—Cardiac Hypertrophic Response—TGFB1—idiopathic pulmonary fibrosis	0.00153	0.00411	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—FAM13A—idiopathic pulmonary fibrosis	0.00153	0.00411	CbGpPWpGaD
Ponatinib—LYN—Cell surface interactions at the vascular wall—FN1—idiopathic pulmonary fibrosis	0.0015	0.00401	CbGpPWpGaD
Ponatinib—SRC—Rac1/Pak1/p38/MMP-2 pathway—FN1—idiopathic pulmonary fibrosis	0.00148	0.00398	CbGpPWpGaD
Ponatinib—ABL1—DNA Damage Response (only ATM dependent)—PLAU—idiopathic pulmonary fibrosis	0.00148	0.00398	CbGpPWpGaD
Ponatinib—PDGFRA—Cardiac Progenitor Differentiation—TGFB1—idiopathic pulmonary fibrosis	0.00147	0.00394	CbGpPWpGaD
Ponatinib—SRC—Androgen receptor signaling pathway—SMAD3—idiopathic pulmonary fibrosis	0.00147	0.00393	CbGpPWpGaD
Ponatinib—LYN—IL-3 Signaling Pathway—TGFB1—idiopathic pulmonary fibrosis	0.00138	0.0037	CbGpPWpGaD
Ponatinib—KDR—Focal Adhesion—FN1—idiopathic pulmonary fibrosis	0.00137	0.00368	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—FAM13A—idiopathic pulmonary fibrosis	0.00133	0.00358	CbGpPWpGaD
Ponatinib—FGFR2—Regulation of Actin Cytoskeleton—FN1—idiopathic pulmonary fibrosis	0.00132	0.00353	CbGpPWpGaD
Ponatinib—SRC—Senescence and Autophagy in Cancer—SMAD3—idiopathic pulmonary fibrosis	0.00128	0.00345	CbGpPWpGaD
Ponatinib—SRC—Syndecan-2-mediated signaling events—TGFB1—idiopathic pulmonary fibrosis	0.00128	0.00343	CbGpPWpGaD
Ponatinib—FGFR1—Endochondral Ossification—TGFB1—idiopathic pulmonary fibrosis	0.00127	0.0034	CbGpPWpGaD
Ponatinib—LCK—Cell surface interactions at the vascular wall—FN1—idiopathic pulmonary fibrosis	0.00123	0.00329	CbGpPWpGaD
Ponatinib—FGFR1—Regulation of Actin Cytoskeleton—FN1—idiopathic pulmonary fibrosis	0.00123	0.00329	CbGpPWpGaD
Ponatinib—PDGFRA—Regulation of Actin Cytoskeleton—FN1—idiopathic pulmonary fibrosis	0.00122	0.00328	CbGpPWpGaD
Ponatinib—SRC—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—idiopathic pulmonary fibrosis	0.00113	0.00304	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—TOLLIP—idiopathic pulmonary fibrosis	0.00113	0.00303	CbGpPWpGaD
Ponatinib—TEK—Hemostasis—PLAU—idiopathic pulmonary fibrosis	0.00112	0.00302	CbGpPWpGaD
Ponatinib—SRC—Senescence and Autophagy in Cancer—PLAU—idiopathic pulmonary fibrosis	0.00111	0.00299	CbGpPWpGaD
Ponatinib—KIT—Immune System—TOLLIP—idiopathic pulmonary fibrosis	0.00111	0.00298	CbGpPWpGaD
Ponatinib—ABCB1—HIF-1-alpha transcription factor network—SMAD3—idiopathic pulmonary fibrosis	0.0011	0.00296	CbGpPWpGaD
Ponatinib—FGFR2—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—idiopathic pulmonary fibrosis	0.00109	0.00293	CbGpPWpGaD
Ponatinib—SRC—Interleukin-11 Signaling Pathway—TGFB1—idiopathic pulmonary fibrosis	0.00109	0.00293	CbGpPWpGaD
Ponatinib—SRC—Cell surface interactions at the vascular wall—FN1—idiopathic pulmonary fibrosis	0.00109	0.00291	CbGpPWpGaD
Ponatinib—SRC—TGF-beta Signaling Pathway—SMAD3—idiopathic pulmonary fibrosis	0.00107	0.00287	CbGpPWpGaD
Ponatinib—PDGFRA—Allograft Rejection—TGFB1—idiopathic pulmonary fibrosis	0.00107	0.00286	CbGpPWpGaD
Ponatinib—ABCB1—Transmembrane transport of small molecules—ATP11A—idiopathic pulmonary fibrosis	0.00106	0.00285	CbGpPWpGaD
Ponatinib—ABL1—Regulation of Telomerase—TGFB1—idiopathic pulmonary fibrosis	0.00106	0.00283	CbGpPWpGaD
Ponatinib—KDR—Extracellular matrix organization—FN1—idiopathic pulmonary fibrosis	0.00105	0.00283	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—FAM13A—idiopathic pulmonary fibrosis	0.00105	0.00283	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—TOLLIP—idiopathic pulmonary fibrosis	0.00105	0.00282	CbGpPWpGaD
Ponatinib—SRC—Aryl Hydrocarbon Receptor Pathway—TGFB1—idiopathic pulmonary fibrosis	0.00105	0.00282	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—TOLLIP—idiopathic pulmonary fibrosis	0.00105	0.00282	CbGpPWpGaD
Ponatinib—TEK—Hemostasis—FN1—idiopathic pulmonary fibrosis	0.00105	0.0028	CbGpPWpGaD
Ponatinib—SRC—Senescence and Autophagy in Cancer—FN1—idiopathic pulmonary fibrosis	0.00104	0.00278	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—FAM13A—idiopathic pulmonary fibrosis	0.00103	0.00278	CbGpPWpGaD
Ponatinib—ABCB1—HIF-1-alpha transcription factor network—TERT—idiopathic pulmonary fibrosis	0.00101	0.00271	CbGpPWpGaD
Ponatinib—PDGFRA—Focal Adhesion—FN1—idiopathic pulmonary fibrosis	0.00101	0.0027	CbGpPWpGaD
Ponatinib—SRC—IL-3 Signaling Pathway—TGFB1—idiopathic pulmonary fibrosis	0.001	0.00268	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—FAM13A—idiopathic pulmonary fibrosis	0.000982	0.00263	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—FAM13A—idiopathic pulmonary fibrosis	0.000979	0.00263	CbGpPWpGaD
Ponatinib—SRC—TGF-beta Signaling Pathway—TERT—idiopathic pulmonary fibrosis	0.000979	0.00263	CbGpPWpGaD
Ponatinib—LYN—Immune System—TOLLIP—idiopathic pulmonary fibrosis	0.000926	0.00248	CbGpPWpGaD
Ponatinib—ABL1—Immune System—TOLLIP—idiopathic pulmonary fibrosis	0.000922	0.00247	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—FAM13A—idiopathic pulmonary fibrosis	0.000864	0.00232	CbGpPWpGaD
Ponatinib—SRC—TGF-beta Signaling Pathway—FN1—idiopathic pulmonary fibrosis	0.000862	0.00231	CbGpPWpGaD
Ponatinib—BCR—Disease—SMAD3—idiopathic pulmonary fibrosis	0.000829	0.00222	CbGpPWpGaD
Ponatinib—KDR—Developmental Biology—SMAD3—idiopathic pulmonary fibrosis	0.000792	0.00212	CbGpPWpGaD
Ponatinib—LYN—Platelet activation, signaling and aggregation—FN1—idiopathic pulmonary fibrosis	0.000787	0.00211	CbGpPWpGaD
Ponatinib—ABL1—Cell Cycle—TGFB1—idiopathic pulmonary fibrosis	0.000764	0.00205	CbGpPWpGaD
Ponatinib—LCK—Immune System—TOLLIP—idiopathic pulmonary fibrosis	0.000759	0.00204	CbGpPWpGaD
Ponatinib—BCR—Disease—TERT—idiopathic pulmonary fibrosis	0.000759	0.00203	CbGpPWpGaD
Ponatinib—ABL1—DNA Damage Response (only ATM dependent)—TGFB1—idiopathic pulmonary fibrosis	0.000724	0.00194	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—FAM13A—idiopathic pulmonary fibrosis	0.000708	0.0019	CbGpPWpGaD
Ponatinib—SRC—Immune System—TOLLIP—idiopathic pulmonary fibrosis	0.000672	0.0018	CbGpPWpGaD
Ponatinib—LCK—Platelet activation, signaling and aggregation—FN1—idiopathic pulmonary fibrosis	0.000645	0.00173	CbGpPWpGaD
Ponatinib—SRC—Focal Adhesion—FN1—idiopathic pulmonary fibrosis	0.000644	0.00173	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—FAM13A—idiopathic pulmonary fibrosis	0.000627	0.00168	CbGpPWpGaD
Ponatinib—FGFR1—MAPK Signaling Pathway—TGFB1—idiopathic pulmonary fibrosis	0.000585	0.00157	CbGpPWpGaD
Ponatinib—FGFR4—Disease—SMAD3—idiopathic pulmonary fibrosis	0.000584	0.00157	CbGpPWpGaD
Ponatinib—FGFR1—Developmental Biology—SMAD3—idiopathic pulmonary fibrosis	0.000583	0.00156	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	0.00058	0.00156	CbGpPWpGaD
Ponatinib—SRC—Platelet activation, signaling and aggregation—FN1—idiopathic pulmonary fibrosis	0.000571	0.00153	CbGpPWpGaD
Ponatinib—KDR—Extracellular matrix organization—TGFB1—idiopathic pulmonary fibrosis	0.000554	0.00149	CbGpPWpGaD
Ponatinib—TEK—Hemostasis—TGFB1—idiopathic pulmonary fibrosis	0.000549	0.00147	CbGpPWpGaD
Ponatinib—SRC—Senescence and Autophagy in Cancer—TGFB1—idiopathic pulmonary fibrosis	0.000544	0.00146	CbGpPWpGaD
Ponatinib—FGFR4—Disease—TERT—idiopathic pulmonary fibrosis	0.000535	0.00143	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	0.000531	0.00142	CbGpPWpGaD
Ponatinib—FGFR1—Integrated Pancreatic Cancer Pathway—TGFB1—idiopathic pulmonary fibrosis	0.000528	0.00142	CbGpPWpGaD
Ponatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—TGFB1—idiopathic pulmonary fibrosis	0.000527	0.00141	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—SMAD3—idiopathic pulmonary fibrosis	0.000513	0.00138	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—SMAD3—idiopathic pulmonary fibrosis	0.00051	0.00137	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	0.000468	0.00125	CbGpPWpGaD
Ponatinib—ABL1—Integrated Pancreatic Cancer Pathway—TGFB1—idiopathic pulmonary fibrosis	0.000462	0.00124	CbGpPWpGaD
Ponatinib—SRC—TGF-beta Signaling Pathway—TGFB1—idiopathic pulmonary fibrosis	0.000453	0.00121	CbGpPWpGaD
Ponatinib—LYN—Hemostasis—PLAU—idiopathic pulmonary fibrosis	0.000436	0.00117	CbGpPWpGaD
Ponatinib—ABL1—Hemostasis—PLAU—idiopathic pulmonary fibrosis	0.000434	0.00116	CbGpPWpGaD
Ponatinib—FGFR3—Disease—SMAD3—idiopathic pulmonary fibrosis	0.000432	0.00116	CbGpPWpGaD
Ponatinib—LYN—Platelet activation, signaling and aggregation—TGFB1—idiopathic pulmonary fibrosis	0.000413	0.00111	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	0.000409	0.0011	CbGpPWpGaD
Ponatinib—LYN—Hemostasis—FN1—idiopathic pulmonary fibrosis	0.000406	0.00109	CbGpPWpGaD
Ponatinib—ABCB1—Allograft Rejection—TGFB1—idiopathic pulmonary fibrosis	0.000404	0.00108	CbGpPWpGaD
Ponatinib—ABL1—Hemostasis—FN1—idiopathic pulmonary fibrosis	0.000404	0.00108	CbGpPWpGaD
Ponatinib—FGFR3—Disease—TERT—idiopathic pulmonary fibrosis	0.000395	0.00106	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	0.000374	0.001	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—SMAD3—idiopathic pulmonary fibrosis	0.000372	0.000998	CbGpPWpGaD
Ponatinib—LCK—Hemostasis—PLAU—idiopathic pulmonary fibrosis	0.000358	0.000959	CbGpPWpGaD
Ponatinib—BCR—Disease—TGFB1—idiopathic pulmonary fibrosis	0.000351	0.000941	CbGpPWpGaD
Ponatinib—LCK—Platelet activation, signaling and aggregation—TGFB1—idiopathic pulmonary fibrosis	0.000339	0.000909	CbGpPWpGaD
Ponatinib—SRC—Integrated Pancreatic Cancer Pathway—TGFB1—idiopathic pulmonary fibrosis	0.000337	0.000904	CbGpPWpGaD
Ponatinib—KDR—Developmental Biology—TGFB1—idiopathic pulmonary fibrosis	0.000335	0.0009	CbGpPWpGaD
Ponatinib—LCK—Hemostasis—FN1—idiopathic pulmonary fibrosis	0.000332	0.000891	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	0.00033	0.000884	CbGpPWpGaD
Ponatinib—SRC—Hemostasis—PLAU—idiopathic pulmonary fibrosis	0.000317	0.000849	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	0.000302	0.000811	CbGpPWpGaD
Ponatinib—SRC—Platelet activation, signaling and aggregation—TGFB1—idiopathic pulmonary fibrosis	0.0003	0.000804	CbGpPWpGaD
Ponatinib—FGFR2—Disease—SMAD3—idiopathic pulmonary fibrosis	0.000297	0.000797	CbGpPWpGaD
Ponatinib—SRC—Hemostasis—FN1—idiopathic pulmonary fibrosis	0.000294	0.000789	CbGpPWpGaD
Ponatinib—KIT—Disease—SMAD3—idiopathic pulmonary fibrosis	0.000292	0.000782	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	0.000277	0.000743	CbGpPWpGaD
Ponatinib—FGFR1—Disease—SMAD3—idiopathic pulmonary fibrosis	0.000277	0.000743	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—SMAD3—idiopathic pulmonary fibrosis	0.000276	0.000741	CbGpPWpGaD
Ponatinib—FGFR2—Disease—TERT—idiopathic pulmonary fibrosis	0.000272	0.000729	CbGpPWpGaD
Ponatinib—KIT—Disease—TERT—idiopathic pulmonary fibrosis	0.000267	0.000716	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	0.000263	0.000707	CbGpPWpGaD
Ponatinib—FGFR1—Disease—TERT—idiopathic pulmonary fibrosis	0.000253	0.00068	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—TERT—idiopathic pulmonary fibrosis	0.000253	0.000678	CbGpPWpGaD
Ponatinib—FGFR4—Disease—TGFB1—idiopathic pulmonary fibrosis	0.000247	0.000663	CbGpPWpGaD
Ponatinib—FGFR1—Developmental Biology—TGFB1—idiopathic pulmonary fibrosis	0.000247	0.000662	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	0.000246	0.000659	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	0.000244	0.000654	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	0.000241	0.000647	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—TGFB1—idiopathic pulmonary fibrosis	0.000217	0.000582	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—TGFB1—idiopathic pulmonary fibrosis	0.000216	0.00058	CbGpPWpGaD
Ponatinib—LYN—Hemostasis—TGFB1—idiopathic pulmonary fibrosis	0.000213	0.000571	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	0.000212	0.00057	CbGpPWpGaD
Ponatinib—ABL1—Hemostasis—TGFB1—idiopathic pulmonary fibrosis	0.000212	0.000569	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	0.000208	0.000558	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	0.000204	0.000548	CbGpPWpGaD
Ponatinib—LCK—Disease—SMAD3—idiopathic pulmonary fibrosis	0.0002	0.000535	CbGpPWpGaD
Ponatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—idiopathic pulmonary fibrosis	0.000199	0.000535	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	0.000194	0.00052	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	0.000193	0.000519	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	0.00019	0.000511	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	0.000187	0.000502	CbGpPWpGaD
Ponatinib—FGFR3—Disease—TGFB1—idiopathic pulmonary fibrosis	0.000183	0.00049	CbGpPWpGaD
Ponatinib—LCK—Disease—TERT—idiopathic pulmonary fibrosis	0.000183	0.00049	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	0.000177	0.000476	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	0.000177	0.000475	CbGpPWpGaD
Ponatinib—SRC—Disease—SMAD3—idiopathic pulmonary fibrosis	0.000177	0.000474	CbGpPWpGaD
Ponatinib—LCK—Hemostasis—TGFB1—idiopathic pulmonary fibrosis	0.000175	0.000468	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	0.000173	0.000464	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	0.000171	0.000457	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	0.000168	0.00045	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	0.000165	0.000442	CbGpPWpGaD
Ponatinib—SRC—Disease—TERT—idiopathic pulmonary fibrosis	0.000162	0.000434	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—TGFB1—idiopathic pulmonary fibrosis	0.000158	0.000423	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	0.000156	0.000419	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	0.000156	0.000419	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	0.000156	0.000418	CbGpPWpGaD
Ponatinib—SRC—Hemostasis—TGFB1—idiopathic pulmonary fibrosis	0.000155	0.000415	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	0.00014	0.000375	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	0.000137	0.000369	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	0.000128	0.000343	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	0.000128	0.000343	CbGpPWpGaD
Ponatinib—FGFR2—Disease—TGFB1—idiopathic pulmonary fibrosis	0.000126	0.000337	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	0.000124	0.000332	CbGpPWpGaD
Ponatinib—KIT—Disease—TGFB1—idiopathic pulmonary fibrosis	0.000124	0.000331	CbGpPWpGaD
Ponatinib—FGFR1—Disease—TGFB1—idiopathic pulmonary fibrosis	0.000117	0.000314	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—TGFB1—idiopathic pulmonary fibrosis	0.000117	0.000314	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	0.000113	0.000304	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	0.000113	0.000302	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	0.000112	0.000299	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	9.98e-05	0.000268	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	8.81e-05	0.000236	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	8.65e-05	0.000232	CbGpPWpGaD
Ponatinib—LCK—Disease—TGFB1—idiopathic pulmonary fibrosis	8.45e-05	0.000227	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	8.21e-05	0.00022	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	8.19e-05	0.00022	CbGpPWpGaD
Ponatinib—SRC—Disease—TGFB1—idiopathic pulmonary fibrosis	7.48e-05	0.000201	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	7.22e-05	0.000194	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	5.92e-05	0.000159	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	5.24e-05	0.000141	CbGpPWpGaD
